Prosecution Insights
Prosecution Insights
Technology area: Medical Devices & Mechanical Engineering
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Herlev Gentofte Hospital currently manages 1 pending office action within the Medical Devices & Mechanical Engineering technology area. This action is located within 1 distinct art unit, which indicates a specific technical focus for the company's current intellectual property. The concentration in 1 art unit suggests that the pending matter is subject to a particular set of examination guidelines and technical classifications.
The prosecution involves 1 distinct examiner, HOEKSTRA, JEFFREY GERBEN. As the busiest examiner for the portfolio, HOEKSTRA, JEFFREY GERBEN is responsible for 1 pending office action. This creates a 1 to 1 relationship between the examiner and the company's pending workload, simplifying the communication process between the applicant and the USPTO.
Practitioners should note that with 1 pending office action and 1 distinct examiner, the current prosecution strategy is very centralized. This centralization within the Medical Devices & Mechanical Engineering sector allows for a focused response to USPTO inquiries. The presence of only 1 distinct art unit further streamlines the technical requirements for the pending application, as all current feedback comes from HOEKSTRA, JEFFREY GERBEN.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| HOEKSTRA, JEFFREY GERBEN | 1 | 56.5% | +39.1% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18694477 | TRANSDERMAL ALLERGY TESTING | HOEKSTRA, JEFFREY GERBEN | 23d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18694477 | TRANSDERMAL ALLERGY TESTING | HOEKSTRA, JEFFREY GERBEN | 23d overdue |
| Art Unit | Apps |
|---|---|
| 3791 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18694477 | TRANSDERMAL ALLERGY TESTING | HOEKSTRA, JEFFREY GERBEN | 3791 | §102§112 | Non-Final OA | 23d overdue | Pending | Mar 22, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial